Peripheral and central auditory function in adults with epilepsy and treated with carbamazepine

References

• Osuntokun BO. Epilepsy in the African continent. In: Peny JK, editor. Epilepsy: the eighth international symposium, P.P. New York (NY): Ravan Press; 1977, p. 365–78.
   Google Scholar
• Hauser WA. Incidence and prevalence. In: Engel J, Pedley TA, editors. Epilepsy: a comprehensive textbook. Philadelphia (PA): Lippincott-Raven; 1997, p. 47–57.
   Google Scholar
• Kandil MR, Ahmed WA, Sayed AM, et al. Pattern of epilepsy in childhood and adolescence: a hospital-based study. African J Neurol Sci. 2007;26:33–45.
   Google Scholar
• Engel J. Etiology as a risk factor for medically refractory epilepsy: a case for early surgical intervention. Neurology. 1998;51(5):1243–1244.
   PubMed Web of Science ®Google Scholar
• Hamed SA. The aspects and mechanisms of cognitive alterations in epilepsy: the role of antiepileptic medications. CNS Neurosci Ther. 2009;15(2):134–156.
   PubMed Web of Science ®Google Scholar
• Beyenburg S, Mitchell AJ, Schmidt D, et al. Anxiety in patients with epilepsy: systematic review and suggestions for clinical management. Epilepsy Behav. 2005;7(2):161–171.
   PubMed Web of Science ®Google Scholar
• Kobau R, Gilliam F, Thurman DJ. Prevalence of self-reported epilepsy or seizure disorder and its associations with self-reported depression and anxiety: results from the 2004 Health Styles Survey. Epilepsia. 2006;47(11):1915–1921.
   PubMed Web of Science ®Google Scholar
• Hamed SA, Elserogy YE, Abd-ElHafeez HA. Psychopathological and peripheral level of neurobiological correlates of obsessive compulsive symptoms with epilepsy: a hospital-based study. Epilepsy Behav. 2013;27(2):409–415.
   PubMed Web of Science ®Google Scholar
• Calandre EP, Rodriguez-Lopez C, Blazquez A, et al. Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital. Acta Neurol Scand. 1991;83(4):250–253.
   PubMed Web of Science ®Google Scholar
• Hamed SA, Hamed EA, Hamdy R, et al. Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy. Epilepsy Res. 2007;74(2–3):183–192.
   PubMed Web of Science ®Google Scholar
• Kim DW, Lee SY, Shon YM, et al. Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy. Epilepsia. 2013;54(10):e146–149.
   PubMed Web of Science ®Google Scholar
• Hamed SA. Leptin and insulin homeostasis in epilepsy: relation to weight adverse conditions. Epilepsy Res. 2007;75(1):1–9.
   PubMed Web of Science ®Google Scholar
• Hamed SA. Antiepileptic drugs influences on body weight in people with epilepsy. Expert Rev Clin Pharmacol. 2015;8(1):103–114.
   PubMed Web of Science ®Google Scholar
• Penfield W, Jasper H. Epilepsy and the functional anatomy of the human brain. Boston: Little Brown and Co.; 1954.
   Google Scholar
• Berkovic SF, McIntosh A, Howell RA, et al. Familial temporal lobe epilepsy: a common disorder identified in twins. Ann Neurol. 1996;40(2):227–235.
   PubMed Web of Science ®Google Scholar
• Boatman DF, Lesser RP, Crone NE, et al. Speech recognition impairments in patients with intractable right temporal lobe epilepsy. Epilepsia. 2006;47(8):1397–1401.
   PubMed Web of Science ®Google Scholar
• Miyajima M, Ohta K, Hara K, et al. Abnormal mismatch negativity for pure-tone sounds in temporal lobe epilepsy. Epilepsy Res. 2011;94(3):149–157.
   PubMed Web of Science ®Google Scholar
• Lavasani AN, Mohammadkhani G, Motamedi M, et al. Auditory temporal processing in patients with temporal lobe epilepsy. Epilepsy Behav. 2016;60:81–85.
   PubMed Web of Science ®Google Scholar
• Liu Z, Wang Q, You Y, et al. The role of the temporal pole in modulating primitive auditory memory. Neurosci Lett. 2016;619:196–202.
   PubMed Web of Science ®Google Scholar
• Tateno A, Omura I. Two cases of auditory disturbance caused by carbamazepine. No To Hattatsu. 2000;32(5):420–423.
   PubMedGoogle Scholar
• Chaloupka V, Mitchell S, Muirhead R. Observation of a reversible, medication-induced change in pitch perception. J Acoust Soc Am. 1994;96(1):145–149.
   PubMed Web of Science ®Google Scholar
• Konno S, Yamazaki E, Kudoh M, et al. Half pitch lower sound perception caused by carbamazepine. Intern Med. 2003;42(9):880–883.
   PubMed Web of Science ®Google Scholar
• de la Cruz M, Bance M, Carbamazepine-induced sensorineural hearing loss. Arch Otolaryngol Head Neck Surg. 1999;125(2):225–227.
   PubMedGoogle Scholar
• Miyaoka T, Seno H, Itoga M, et al. Reversible pitch perception deficit caused by carbamazepine. Clin Neuropharmacol. 2000;23(4):219–221.
   PubMed Web of Science ®Google Scholar
• Gur-Ozmen S, Nirmalananthan N, von Oertzen TJ. Change of pitch due to carbamazepine and oxcarbazepine independently. Seizure. 2013;22(2):162–163.
   PubMed Web of Science ®Google Scholar
• Geraldini C, Faedda MT, Sideri G. Anticonvulsant therapy and its possible consequences on peripheral nervous system: a neurographic study. Epilepsia 1984;25(4):502–505.
   PubMed Web of Science ®Google Scholar
• Mervaala E, Keränen T, Tiihonen P, et al. The effects of carbamazepine and sodium valproate on SEPs and BAEPs. Electroencephalogr Clin Neurophysiol. 1987;68(6):475–478.
   PubMedGoogle Scholar
• Medaglini S, Filippi M, Smirne S, et al. Effects of long-lasting antiepileptic therapy on brainstem auditory evoked potentials. Neuropsychobiology. 1988;19(2):104–107.
   PubMed Web of Science ®Google Scholar
• Mony L, Pineau P, Pouplard F, et al. Brain stem auditory evoked potentials in children with partial seizures. Neurophysiol Clin. 1989;19(1):37–46.
   PubMedGoogle Scholar
• Yuksel A, Senocak D, Sozuer D, et al. Effects of carbamazepine and valproate on brainstem auditory evoked potentials in epileptic children. Child's Nerv Syst. 1995;11(8):474–477.
   PubMed Web of Science ®Google Scholar
• Japaridze G, Kvernadze D, Geladze T, et al. Auditory brainstem response, middle-latency response, and slow cortical potential in patients with partial epilepsy. Seizure. 1997;6(6):449–456.
   PubMed Web of Science ®Google Scholar
• Wakamoto H, Kume A, Nakano N. Elevated pitch perception owing to carbamazepine-activating effect on the peripheral auditory system: auditory brainstem response study. J Child Neurol. 2004;19(6):453–455.
   PubMed Web of Science ®Google Scholar
• Hamed SA, Darwish ES, Youssef AH, et al. The effect of antiepileptic drugs on the evoked potentials of children with idiopathic epilepsy. J Pediatric Epilepsy. 2012;2:103–112.
   Google Scholar
• Fukai M, Motomura N, Kobayashi S, et al. Event-related potential (P300) in epilepsy. Acta Neurol Scand. 1990;82(3):197–202.
   PubMed Web of Science ®Google Scholar
• Rodin E, Khabbazeh Z, Twitty G, et al. The cognitive evoked potential in epilepsy patients. Clin Electroencephalogr. 1989;20(3):176–182.
   PubMedGoogle Scholar
• Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the commission on classification and terminology of the international league against epilepsy. Epilepsia. 1981;22(4):489–501.
   PubMed Web of Science ®Google Scholar
• Northern JL, Downs MP. Hearing and hearing loss in children. In: Butter, J. editor. Hearing in children. Baltimore: Williams and Wikins; 1991, p. 1–31.
   Google Scholar
• Lightfoot GR. ABR screening for acoustic neuromata: the role of rate-induced latency shift measurements. Br J Audiol. 1992;26(4):217–227.
   PubMed Web of Science ®Google Scholar
• Tanaka H, Komatsuzaki A, Hentona H. Usefulness of auditory brainstem responses at high stimulus rates in the diagnosis of acoustic neuroma ORL J Otorhinolaryngol Relat Spec. 1996;58(4):224–228.
   PubMed Web of Science ®Google Scholar
• Burkard RF, Sims D. The human auditory brainstem response to high click rates: aging effects. Am J Audiol. 2001;10(2):53–61.
   PubMedGoogle Scholar
• Verrotti A, Trotta D, Cutarella R, et al. Effects of antiepileptic drugs on evoked potentials in epileptic children. Pediatr Neurol. 2000;23(5):397–402.
   PubMed Web of Science ®Google Scholar
• Rowe MJ. Normal variability of the brain-stem auditory evoked response in young and old adult subjects. Electroencephalogr Clin Neurophysiol. 1978;44(4):459–470.
   PubMedGoogle Scholar
• Polich J. P300 clinical utility and control of variability. J Clin Neurophysiol. 1998:15(1):14–33.
   PubMed Web of Science ®Google Scholar
• Gelfand, S. Acoustic reflex threshold tenth percentiles and functional hearing impairment. J Am Acad Audiol. 1994;5(1):10–16.
   PubMedGoogle Scholar
• Fausti SA, Henry JA, Schaffer HI, et al. High-frequency monitoring for early detection of cisplatin ototoxicity. Arch Otolaryngol Head Neck Surg. 1993;119(6):661–666.
   PubMedGoogle Scholar
• Selim ZI, Hamed SA, Elattar AM. Peripheral and central auditory pathways function with rheumatoid arthritis. Int J Clin Rheumatol. 2015;10:85–96.
   Google Scholar
• Hamed SA, Haridi MA, Ali AM, et al. Peripheral and central auditory pathways function in patients with type 2 diabetes mellitus. J Neurol Neurosci. 2014;5:2.
   Google Scholar
• Brown RD, Feldman AM. Pharmacology of hearing and ototoxicity. Annu Rev Pharmacol Toxicol. 1978;18:233–252.
   PubMed Web of Science ®Google Scholar
• Bergstrom L, Thompson PL. Ototoxicity. In: Nourther JL, editor. Hearing disorders. 2. Boston: Little Brown; 1984, p. 253–266.
   Google Scholar
• Cary R, Clarke S, Delic J. Effects of combined exposure to noise and toxic substances-critical review of the literature. Ann Occup Hyg. 1997;41(4):455–465.
   PubMedGoogle Scholar
• Lee CA, Mistry D, Uppal S, Coatesworth, AP. Otologic side effects of drugs. J Laryngol Otol. 2005;119(4):267–271.
   PubMed Web of Science ®Google Scholar
• Panjwani U, Singh SH, sel Vamurthy W, et al. Brainstem auditory evoked potentials in epileptics on different anti-epileptic drugs. Indian J Physiol Pharmacol. 1996;40(1):29–34.
   PubMedGoogle Scholar
• Zgorzalewicz M. Bimodal evoked potentials during long-term therapy with conventional or slow release preparations of carbamazepine and valproic acid in children and adolescents with epilepsy. Neurol Neurochir Pol. 2000;34(Suppl 1):119–128.
   PubMedGoogle Scholar
• Sitges M, Nekrassov V. Acute and chronic effects of carbamazepine, phenytoin, valproate and vinpocetine on BAEP parameters and threshold in the guinea pig. Clin Neurophysiol. 2007;118(2):420–426.
   PubMed Web of Science ®Google Scholar
• Boiko T, Rasband MN, Levinson SR, et al. Compact myelin dictates the differential targeting of two sodium channel isoforms in the same axon. Neuron. 2001;30(1):91–104.
   PubMed Web of Science ®Google Scholar
• Dib-Hajj S, Black A, Cummins TR, et al. NaN/Nav1.9: a sodium channel with unique properties. Trends Neurosci. 2002;25(5):253–259.
   PubMed Web of Science ®Google Scholar
• Macdonald RL. Carbamazepine-mechanisms of action. In: Levy R, Mattson R, Meldrum B, Penry JK, Dreifuss FE, editors. Antiepileptic drugs. 3rd ed. New York (NY): Raven Press, Ltd.; 1989, p. 447–455.
   Google Scholar
• American Speech-Language-Hearing Association (ASHA). Guidelines for Audiologic Screening; 1997. http://www.asha.org/policy/GL1997-00199/
   Google Scholar
• Rudic M, Keogh I, Wagner R, et al. The pathophysiology of otosclerosis: review of current research. Hear Res. 2015;330(Pt A):51–56.
   PubMed Web of Science ®Google Scholar